- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Evan Stepp: Patient Concern Over EVALI Appears to Have Faded
Evan L. Stepp, MD, FCCP, CPE, a pulmonologist at National Jewish Health, discusses an apparent change in attitudes among patients in the wake of 2019’s e-cigarette or vaping use–associated lung injury (EVALI) crisis.
Evan L. Stepp, MD, FCCP, CPE, a pulmonologist at National Jewish Health, director of the Highlands Ranch Clinic, and an assistant professor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, discusses an apparent change in attitudes among patients in the wake of 2019's e-cigarette or vaping use-associated lung injury (EVALI) crisis.
Transcript
The FDA declared vaping an epidemic in 2018, and then right before the pandemic, we had EVALI. As a pulmonologist, I'm wondering what trends you've observed in terms of patient behavior?
Initially, late 2019, definitely, patients had heard about EVALI, and even my vapers were asking about it sometimes, and honestly since the pandemic, that's kind of faded away. I think, unfortunately, the pandemic kind of covered up the ongoing vaping epidemic, hence my wanting to make a presentation about this, right? The CDC stopped tracking EVALI cases back in March of last year, I guess again because of the pandemic. So it's kind of faded. So, at this point, in late 2021, 2 years after EVALI—or more than that—I think people may have a slightly increased sense that vapes or e-cigarettes could be dangerous, but not as strong as at least initially felt.
Addressing Financial Aid and Patient Independence as Part of Atopic Dermatitis Care
March 13th 2025Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition were emphasized at this year’s 2025 American Academy of Dermatology meeting.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir
March 13th 2025The combination of doravirine plus islatravir was noninferior to bictegravir/emtricitabine/tenofovir alafenamide and oral antiretroviral therapy in patients who switched to doravirine plus islatravir.
Read More
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
